This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
LL-37 induced significant skin inflammation in mice, which was reduced in Nlrp3-deficient mice.
Why it matters
Understanding the role of LL-37 in rosacea can help develop targeted therapies for this common skin condition. It highlights the importance of the NLRP3 inflammasome in skin inflammation.
How the study worked
The study used in vitro experiments with macrophages and in vivo tests on mice to assess LL-37's effects on inflammation.
What this study cannot tell us
The study primarily used animal models, which may not fully replicate human rosacea. Further research is needed to confirm these findings in humans.
Read the original research
Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an NLRP3-Dependent Manner.
The Journal of investigative dermatology, 141(12), 2885-2894.e5
Citation
Yoon, Sung-Hyun; Hwang, Inhwa; Lee, Eunju; Cho, Hyo-Joung; Ryu, Ju Hee; Kim, Tae-Gyun; Yu, Je-Wook. (2021). Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an NLRP3-Dependent Manner.. The Journal of investigative dermatology, 141(12), 2885-2894.e5. https://doi.org/10.1016/j.jid.2021.02.745